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in cartilage composition, due to deterioration of structural components
like collagen and glycosaminoglycan's (GAGs), precedes morphological
characteristics of cartilage damage in OA patients. With innovative MRI
sequences, including T1r and T2 mapping, it is possible to measure
these early changes in cartilage composition quantitatively by meas-
uring cartilage content. Therefore, the purpose of this study was to
investigate differences in cartilage composition between patients with
PFP and control subjects using quantitative T1r and T2 mapping MRI.
Methods: Patients diagnosed with PFP and healthy control subjects
aged 14-40 years were included in a cross-sectional case-control study.
Measures included a questionnaire, physical examination andMRI at 3T.
MRI comprised morphologic, T1r and T2 mapping sequences. T1r and
T2 mapping sequences were conducted to measure cartilage glyco-
saminoglycan and collagen content, respectively. In-house developed
software was used for image post-processing in order to calculate T1r
and T2 relaxation times (see Figure 1). Higher relaxation times equal
less content and less content equals a lower cartilage quality. Differ-
ences in T1r and T2 relaxation times for trochlear and patellar cartilage
were compared between patients and control subjects by linear
regression analyses, adjusted for potential confounders.
Results: 59 patients and 67 control subjects were included. BMI was
signiﬁcantly lower and sports participation signiﬁcantly higher in
control subjects. Mean T1r relaxation times of the patellar (46.8 vs 46.1
milliseconds (ms), p¼ 0.94) and trochlear cartilage (50.9 vs 50.1 ms, p¼
0.52) did not signiﬁcantly differ between patients and control subjects.
In addition, no signiﬁcant difference was seen between patients and
control subjects inmean T2 relaxation times of patellar (33.4 vs 32.8 ms,
p¼ 0.16) and trochlear cartilage (36.8 vs 36.6 ms, p¼ 0.70) (see Table 1).
Conclusions: Our ﬁndings suggest that cartilage composition, meas-
ured by T1r and T2 mapping, does not play a role in the etiology of PFP.
However, follow-up research will demonstrate potential regional dif-
ferences within the patellar and trochlear cartilage.Table 1
T2 and T1r relaxation times (ms) of trochlear and patellar cartilage (Mean(sd)).
Patients
(N¼59)
Controls
(N¼67)
Mean difference
(þ95% CI)
P-value
T2 trochlea 36.81 (2.55) 36.63 (2.39) 0.18 [-0.69, 1.05] 0.70a
T2 patella 33.41 (2.86) 32.82 (2.56) 0.59 [-0.36, 1.55] 0.16b
T1r trochlea 50.85 (3.57) 50.13 (4.03) 0.72 [-0.72, 2.17] 0.52b
T1r patella 46.79 (4.21) 46.09 (4.43) 0.70 [-0.94, 2.34] 0.94b
sd¼ standard deviation
CI¼ conﬁdence interval
a: adjusted for BMI, sports participation and gender
b: adjusted for BMI and sports participation487
AUTOPHAGY AND OSTEOARTHRITIS DEVELOPMENT
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Purpose: We studied here macro-autophagy (thereafter referred as to
autophagy), a lysosomal recycling process. Lysosomal protein recycling
processes promote cell survival during nutrition depletion by recycling
cellular building blocks. Autophagic activity modulation during osteo-
arthritis progression had been pointed out. However, there is no study
directly studying the role of autophagy in osteoarthritis progression.
Methods: To functionally address the role of autophagy in vivo, we
generated mice with cartilage speciﬁc ablation of Atg5 gene, which is
indispensable for autophagy. We analysed the knee joints of these mice
at 2, 6 and 12 months of age.
Results: At 2 and 6 months, no differences in bone length or bone and
cartilage shape were observed between transgenic animals and wild
type in both strains. However, at the age of 1 year, Atg5cKO joints
showed features of OA whereas wild type animals had healthy joints
(OARSI score: WT: 0,3±0,19; Atg5cKO: 12,66±3,59;N¼5; p¼0,007). The
analysis of 2 months old Atg5cKO knees have higher cell death level
(TUNEL, WT: 5,2±3,13; Atg5cKO: 17,03±4,06; N¼6; p¼0,024). This was
correlated with an increase in caspase 3 (WT: 1,88±0,82; Atg5cKO:
8,45±2,3; N¼5; p¼0,031) and caspase 9 (WT: 0,72±0,39; Atg5cKO:
3,58±1,09; N¼5; p¼0,043) positive cells.
Conclusions: Our results suggest that autophagy protects chondrocytes
from caspase mediated apoptosis and inhibition of this process leads to
chondrocyte apoptosis and tissue breakdown.
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Purpose: The E74-like Factor 3 (Elf3) has been shown to contribute to
cartilage degradation and mediate inﬂammatory responses in chon-
drocytes via up-regulation of downstream targets genes, including
Mmp13. In this study, we aimed to assess whether cartilage-speciﬁc
Elf3 deﬁciency protects against to, or attenuates the progression of
cartilage degradation in vivo, using an a non-invasive mechanical
loading mouse model that triggers OA-like pathology.
Methods: We generated Col2a1CRE-driven cartilage-speciﬁc Elf3-
knockout (Col2Cre:Elf3f/f) mice, that showed no obvious differences in
size, weight and growth plate morphology when compared to wild-
type counterparts. We subjected the left knees of 12-weeks-old male
Col2Cre:Elf3f/f (KO) and Elf3f/f Cre-negative controls (WT) to 1 and 4
weeks of non-invasive mechanical loading, at 9N for 1200 cycles/day.
The right knees were used as non-loaded controls. At 1-week post-
loading, we isolated knee articular cartilages from three KO or threeWT
mice, and the loaded and control cartilages from the KO or WT litter-
mates were pooled together for the isolation of total RNAs and sub-
sequent RTqPCR analyses. At 4-weeks post-loading, knees were
harvested followed by ﬁxation and decalciﬁcation in paraformaldehyde
and EDTA, respectively. Histological assessment of OAwas conducted on
Safranin-O/fast green stained serial coronal sections, following the
OARSI recommendations for assessment of OA in the mouse.
Results: Our initial RTqPCR analyses showed increased Mmp13 and
Ptgs2 expression in the loaded legs of WT animals compared to
unloaded controls. Interestingly, the expression of these genes was
down-regulated in KO animals, highlighting the role of Elf3 in con-
trolling these downstream effectors. Preliminary histological analyses
of WT (n¼3) and KO (n¼3) knee joints at 4-weeks post-loading indi-
cated a trend towards reduced cartilage degradation scores in the KO
animals, which is in agreement with the results obtained by RTqPCR
and with the notion that Elf3 contributes to cartilage degradative
processes.
Conclusions: We here provide preliminary evidence that Elf3 contrib-
utes to cartilage degradation in vivo, using a non-invasive mechanical
loading mouse model. Cartilage-speciﬁc Elf3 KO animals show a trend
towards reduced cartilage erosion following loading, which correlated
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A310with the reduced Mmp13 and Ptgs2 mRNA detected in the KO animals.
The contribution of Elf3 to load-induced cartilage damage and the
identiﬁcation of targets and mechanism of action in vivo merits further
investigation.
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INHIBITION OF CTX-II RELEASE BY CATHEPSIN K INHIBITION IN VIVO
BUT NOT IN VITRO SUGGESTS THAT ANTI-RESORPTIVE THERAPY
PROTECTS CARTILAGE
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Purpose: Loss of subchondral bone precedes both reduced joint space
in human OA and cartilage loss in animal models. This suggests that
resorption of subchondral bone might cause or aggravate cartilage loss.
Consistent with this, anti-resorptives given in vivo suppress release of
CTX-II, a peptide fragment generated from cleavage of type II collagen,
in several species and prevent disease progression in animal models
and in humans. Thus, loss of subchondral bonemay destabilise cartilage
and induce its degradation by chondrocytes. However, an alternative
explanation for suppression of CTX-II has recently been proposed i.e.
that osteoclasts themselves release CTX-II when they resorb calciﬁed
cartilage, so that there is less release when resorption is inhibited. We
therefore tested whether osteoclasts generate CTX-II from cartilage and
if this was done in a MMP- or cathepsin K-dependent manner. We used
osteoclast-induced CTX-I release from subchondral bone as a com-
parator.We also compared the in vitro datawith the effect of a cathepsin
K inhibitor in vivo on urine CTX-I and CTX-II levels in female beagle dogs
subjected to partial medial meniscectomy, an experimental model of
OA1.
Methods: For the in vitro study, human osteoclasts were incubated on
slices of subchondral bone and overlying calciﬁed and hyaline cartilage
(‘bone-cartilage’) taken from patients with OA. CTX-I and CTX-II levels
were measured after a ﬁrst incubation period for 24 h to establish a
baseline release of the two respective biomarkers. The cultures were
then incubated with the selective cathepsin K inhibitor MV061194 (300
nM, n¼4), or the broad spectrumMMP-inhibitor GM6001 (10 mM, n¼4),
or vehicle (n¼4) for another 24 h. Results were expressed as CTX-I or
CTX-II release compared to baseline. In a previously performed exper-
imental dog OA study, female beagle dogs were subjected to partial
medial meniscectomy and treated with the selective cathepsin K
inhibitor MIV-711 (30 mmol/kg p.o., n¼15) or vehicle (p.o., n¼15) for 28
days starting the day before surgery. Urine was collected for assessment
of CTX-I and CTX-II levels and creatinine. All data are expressed as mean
± SEM.
Results: Osteoclast incubation on the bone-cartilage slices increased
CTX-I levels from <LLQ (0.44 nM) to 155 ± 24 nM. CTX-II levels from the
same slices were increased from 34 ± 6 pg/ml to 533 ± 23 pg/ml. As
expected, the cathepsin K inhibitor MV061194 strongly suppressed
CTX-I release (vehicle controls: 76±13% compared to baseline;
MV061194: 26±4%). However, there was no change in CTX-II release in
presence of the cathepsin K inhibitor (vehicle controls: 92±5% com-
pared to baseline; MV061194: 88±8%). In contrast, the MMP inhibitor
GM6001 reduced CTX-II to 45±5% of baseline release. These data
however do not exclude that osteoclasts could release other cleavage
fragments from type II collagen in a cathepsin K-dependent manner. In
female beagle dogs, after 28-day treatment, the selective cathepsin K
inhibitor MIV-711 reduced urinary CTX-I levels to 14±1% compared to
baseline and CTX-II levels to 20±2%.
Conclusions: Osteoclasts release CTX-I and CTX-II from bone/cartilage
explants in vitro. The CTX-I release in vitro is cathepsin K-dependent
while the CTX-II release is not. By contrast, selective cathepsin K
inhibition reduces urinary levels of CTX-I and CTX-II in a similar fashion
in dog. In dog, these reductions translated into structural beneﬁt on
cartilage1. Thus, this provides evidence that the reduction in CTX-II in
vivo by cathepsin K inhibition is probably not caused by direct sup-
pression of osteoclast-evoked CTX-II release. Rather, direct inhibition of
cathepsin K-mediated bone resorption protects cartilage, and thereby
indirectly reduces the release of CTX-II.
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KNEE KINEMATIC DIFFERENCES IN ANTERIOR CRUCIATE LIGAMENT
DEFICIENT SUBJECTS PRIOR TO RECONSTRUCTION IS ASSOCIATED
WITH KNEE T1r CARTILAGE RELAXATION TIME AT LONGITUDINAL
FOLLOW-UP
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Purpose: This study aimed to identify possible biomechanical markers
in gait alterations in anterior cruciate ligament (ACL)-deﬁcient knees
prior to reconstruction to predict T1r relaxation times.
Methods: Subjects: Motion analysis data were recorded at baseline
(n¼49, female:male¼ 20:29, age: 29.63±8.63 years, BMI: 23.8±2.66 kg/
m2) after injury and before ACL reconstruction. Gait Analysis: At base-
line, three-dimensional motion analysis was captured while subjects
walked at a controlled speed (1.33±0.6667 m/s). Lower-extremity kin-
ematics data were recorded using AMTI force plate (Watertown, MA,
USA, sampling frequency ¼ 1000Hz) and Vicon motion capture system
(Oxford Metrics, UK, sampling frequency ¼ 250 Hz). Joint external
moments and impulses were then computed using Visual3D Software
(C-Motion, Germantown, MD, USA). MR Protocol: Of the 49 subjects
that conducted motion analysis at baseline, 39 patients returned 12
months following surgery to conduct MR imaging of both knees using a
3 Tesla scanner (GE healthcare) and an 8-channel knee coil (Invivo).
Comprehensive cartilage T1r relaxation times were calculated using
previously validated and published methods by our group. Cartilage
was divided into subcompartments to examine regional variations in
cartilage health (Figure 1). Mean T1r relaxation times were calculated
for each global compartment and its corresponding subcompartments.
Statistic Analysis: Pearson product correlation coefﬁcients were calcu-
lated between T1r relaxation times at the 12-month timepoint and gait
characteristics obtained at baseline prior to surgery Variables histor-
ically in literature that could be associated with knee osteoarthritis
were examined, such as peak knee extension adduction moments and
impulses, and hip ﬂexion moments.
Results: In injury knees, baseline lower peak hip ﬂexion moment, lower
peak knee extension moment in the 1st half of stance phase and lower
peak knee adduction moment in the 2nd half of stance phase were
signiﬁcantly correlated with increased cartilage T1p at 12-months.
(Table 1)
